Claudia Mitchell
Directeur/Membre du Conseil chez ADOCIA
Profil
Claudia Mitchell is the founder of Halo-Bio RNAi Therapeutics, Inc. which was founded in 2008.
She is currently the Director of Washington Biotechnology & Biomedical Association, Independent Director at Adocia SA, Independent Non-Executive Director at Horama SA, Senior VP-Product & Portfolio Strategy at Astellas Pharma, Inc., and Board Member at Reaction Capital.
Dr. Mitchell's former positions include Director at French-American Chamber of Commerce, Director at Alliance for Regenerative Medicine, and Member of board at Cci France International from 2017 to 2019.
Dr. Mitchell holds an MBA from Ecole Des Ponts Business School and a doctorate from Universite Paris Cite.
Dr. Mitchell is also the founder of Universal Cells, Inc.
Postes actifs de Claudia Mitchell
| Sociétés | Poste | Début |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/04/2019 |
| ADOCIA | Directeur/Membre du Conseil | 21/05/2021 |
| Washington Biotechnology & Biomedical Association | Directeur/Membre du Conseil | - |
Reaction Capital
 Reaction Capital Investment ManagersFinance Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California. | Directeur/Membre du Conseil | 01/07/2019 |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 20/10/2022 |
Anciens postes connus de Claudia Mitchell
| Sociétés | Poste | Fin |
|---|---|---|
| Cci France International | Directeur/Membre du Conseil | 01/02/2019 |
Halo-Bio RNAi Therapeutics, Inc.
 Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Halo-Bio RNAi Therapeutics, Inc. utilizes the novel 'Multivalent RNAi Platform' to develop multi-gene targeting products for the treatment of disease. The firm specializes in RNAi, Biopharmaceuticals, RNA Delivery and Nanoparticles. The company is headquartered in Seattle, WA. | Fondateur | 01/02/2011 |
French-American Chamber of Commerce
 French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Directeur/Membre du Conseil | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Claudia Mitchell
| Ecole Des Ponts Business School | Masters Business Admin |
| Universite Paris Cite | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| ADOCIA | Health Technology |
| Entreprise privées | 8 |
|---|---|
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
| Washington Biotechnology & Biomedical Association | |
Halo-Bio RNAi Therapeutics, Inc.
Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Halo-Bio RNAi Therapeutics, Inc. utilizes the novel 'Multivalent RNAi Platform' to develop multi-gene targeting products for the treatment of disease. The firm specializes in RNAi, Biopharmaceuticals, RNA Delivery and Nanoparticles. The company is headquartered in Seattle, WA. | Health Technology |
| Cci France International | |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California. | Finance |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Commercial Services |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Health Technology |
